Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Cash from Investing Activities (2020 - 2025)

Mirum Pharmaceuticals has reported Cash from Investing Activities over the past 6 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $1.0 million for Q4 2025, up 56.94% from a year ago — trailing twelve months through Dec 2025 was -$24.0 million (up 73.42% YoY), and the annual figure for FY2025 was -$24.0 million, up 73.42%.
  • Cash from Investing Activities for Q4 2025 was $1.0 million at Mirum Pharmaceuticals, up from -$2.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for MIRM hit a ceiling of $108.0 million in Q4 2021 and a floor of -$182.8 million in Q3 2023.
  • Median Cash from Investing Activities over the past 5 years was -$2.1 million (2023), compared with a mean of -$8.3 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 2284.05% in 2021 and later tumbled 124007.69% in 2025.
  • Mirum Pharmaceuticals' Cash from Investing Activities stood at $108.0 million in 2021, then crashed by 75.23% to $26.8 million in 2022, then plummeted by 107.47% to -$2.0 million in 2023, then surged by 132.05% to $641000.0 in 2024, then soared by 56.94% to $1.0 million in 2025.
  • The last three reported values for Cash from Investing Activities were $1.0 million (Q4 2025), -$2.2 million (Q3 2025), and -$6.6 million (Q2 2025) per Business Quant data.